Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06866652 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"

Study acronym: MyaRESP
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2025 to Apr 8, 2026
    • Site details revised
    v3
  2. Start date: May 2025 to Dec 2025v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Individuals with MG (IwMG) experience shortness of breath that may be activity-related, occur at rest and even happen during sleep. Dyspnea is a complex, multidimensional and multifactorial symptom involving sensory perception, cognition and emotion. Identifying the cause(s) of dyspnea in MG may assist in finding therapeutic strategies, reducing discomfort, improving QoL and potentially limiting respiratory deterioration and incidence of MG crisis.
Trial Details
NCT Number NCT06866652
Lead Sponsor Institut de Myologie, France
Collaborators: APHP
Conditions
(from sponsor)		 Myasthenia Gravis, Dyspnea
Related terms Dyspnea, Myasthenia Gravis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov